Three totally different topics
Date: 21/08/2019
Venue: The Plough Hotel 333 Barkly St Footscray , VIC, 3011
Provider: Victorian Eye Surgeons
Contact: Kim Salter, [E] kim@victorianeye.com.au, [P] 8378 1000
Learning Objectives
- Adenoviral Conjunctivitis objectives: 1. To review the biology of Adenovirus, and understand the different subtypes of the virus and their clinical manifestations 2. To explore the typical clinical presentation of Adenoviral conjunctivitis 3. To describe the seasonal pattern of Adenoviral conjunctivitis in Victoria
- Vertical squint review objectives: 1. To understand what vertical fusion range is and ways to measure it. 2. To know what a normal vertical fusion range is and understand what happens to the vertical fusion range in cases of longstanding vertical phoria’s. 3. To understand who benefits from squint surgery and who does not.
- Outcomes of the LEAD study objectives: 1. To be able to identify different drusen sub-types on mutli-modal imaging. 2. To understand OCT bio-markers for disease progression. 3. To understand the potential role for sub-threshold nano-second laser therapy in intermediate AMD.
Max points awarded: 4.50
Session Information
| Name |
|---|
| Vertical squint review |
| Activity Type |
| Face to Face without Assessment |
| Therapeutic? |
| No |
| Manufacturer/Supplier? |
| No |
| Points for attending & Passing Assessment |
| 1.50 |
| Name |
|---|
| Outcomes of the LEAD study |
| Activity Type |
| Face to Face without Assessment |
| Therapeutic? |
| No |
| Manufacturer/Supplier? |
| No |
| Points for attending & Passing Assessment |
| 1.50 |
| Name |
|---|
| Adenoviral conjunctivitis |
| Activity Type |
| Face to Face without Assessment |
| Therapeutic? |
| No |
| Manufacturer/Supplier? |
| No |
| Points for attending & Passing Assessment |
| 1.50 |
| Name | Activity Type | Therapeutic? | Manufacturer/Supplier? | Points for attending & Passing Assessment |
|---|---|---|---|---|
| Vertical squint review | Face to Face without Assessment | No | No | 1.50 |
| Outcomes of the LEAD study | Face to Face without Assessment | No | No | 1.50 |
| Adenoviral conjunctivitis | Face to Face without Assessment | No | No | 1.50 |